MLL-Kolloquium: Dr. Marie Vidal (Centre Antoine Lacassagne, Nice/France): In proton therapy, how to treat a first patient with a prototype?

Lecture Hall (ground floor west) (LMU building, Am Coulombwall 1, Garching)

Lecture Hall (ground floor west)

LMU building, Am Coulombwall 1, Garching


After several years of common development the accelerator building companies IBA (Louvain-la-Neuve, Belgium) and AIMA (Nice, France) built a prototype synchro-cyclotron (S2C2) and in 2016, the Centre Antoine LACASSAGNE (Nice, France) treated the first patient with the first ProteusONE (IBA) protontherapy machine, including the S2C2 and a compact gantry beam line. Treating patients with a prototype includes a lot of challenges and uncertainties about the issue. This talk is about this journey and the experiments achieved with this new prototype: absolute dose measurements, range determination with ionoacoustics etc. The Centre Antoine LACASSAGNE is one of the two proton therapy centers in France and this talk gives also an overview of the proton therapy strategy in France nowadays.

Organized by

Peter Thirolf (LMU) / Norbert Kaiser (TUM)

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now